Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estramustine binds MAP-2 to inhibit microtubule assembly in vitro.

M E Stearns1, K D Tew

  • 1Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, PA 19111.

Journal of Cell Science
|March 1, 1988
PubMed
Summary

Estramustine specifically binds to microtubule-associated protein 2 (MAP-2) in rat brain cells. This binding inhibits microtubule assembly, suggesting a novel mechanism for estramustine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reaction kinetics and targeting to cellular glutathione S-transferase of the glutathione peroxidase mimetic PhSeZnCl and its D,L-polylactide microparticle formulation.

Free radical biology & medicine·2014
Same author

Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome.

Free radical biology & medicine·2014
Same author

Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation.

Free radical biology & medicine·2012
Same author

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2010
Same author

Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.

The Prostate·2009
Same author

Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.

The Prostate·2009

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Microtubule-associated proteins (MAPs) are crucial for microtubule stability and dynamics.
  • Estramustine is a chemotherapy drug with known effects on microtubules.

Purpose of the Study:

  • To investigate the binding affinity of estramustine to rat brain microtubule-associated proteins (MAPs) and purified MAP-2.
  • To determine the effect of estramustine binding on microtubule assembly and disassembly.

Main Methods:

  • In vitro binding assays using [3H]estramustine, gel filtration chromatography, and immunoprecipitation.
  • Scatchard analysis to determine drug-protein affinity (Kd and Bmax).
  • Microtubule assembly/disassembly studies using turbidity measurements, SDS-polyacrylamide gel electrophoresis, and electron microscopy.

Main Results:

  • Estramustine demonstrated specific binding affinity for MAP-2, with a Kd of 15 microM.
  • Each MAP-2 molecule was estimated to bind approximately 20 estramustine molecules.
  • Estramustine (20-60 microM) inhibited MAPs association with microtubules and disrupted MAP-2-driven tubulin assembly, leading to microtubule disassembly.

Conclusions:

  • Estramustine binds specifically to MAPs, particularly MAP-2, in vitro.
  • This specific binding interferes with microtubule dynamics by inhibiting assembly and promoting disassembly.
  • The findings suggest a mechanism of action for estramustine involving direct interaction with MAPs.

Related Experiment Videos